Intra-Cellular Therapies revenue was $22.81 m in FY, 2020
Intra-Cellular Therapies revenue breakdown by business segment: 33.6% from License and collaboration revenue and 66.4% from Grant Revenue
FY, 2015 | FY, 2014 | |
---|---|---|
License and collaboration revenue | $30.66 k | $547.55 k |
Grant Revenue | $60.71 k | $29.76 k |
Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via API.